Evaluation of efficacy and safety of thymus humoral factor-gamma 2 in the management of chronic hepatitis B
- 1 July 1995
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 23 (1) , 21-27
- https://doi.org/10.1016/0168-8278(95)80306-8
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- THFγ2 stimulates cytokine release by peripheral blood mononuclear cells of patients with chronic hepatitis B virus infectionJournal of Hepatology, 1994
- Repeated courses of α-interferon for treatment of chronic hepatitis type BJournal of Hepatology, 1993
- Interferon in the management of chronic hepatitis BDigestive Diseases and Sciences, 1993
- Effect of synthetic thymic humoral factor (THF-γ2) on T cell activities in immunodeficient ageing miceClinical and Experimental Immunology, 1992
- Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis BJournal of Hepatology, 1991
- Chronic Hepatitis BNew England Journal of Medicine, 1990
- Spontaneous production of tumour necrosis factor α and interleukin-1β during interferon-α treatment of chronic HBV infectionThe Lancet, 1990
- Thymic humoral factor .gamma.2: purification and amino acid sequence of an immunoregulatory peptide from calf thymusBiochemistry, 1988
- Approaches to the Treatment of Hepatitis B Virus and Delta-Related Liver DiseaseSeminars in Liver Disease, 1986
- BIOCHEMICAL AND BIOLOGICAL PROPERTIES OF THF IN ANIMAL AND HUMAN MODELSAnnals of the New York Academy of Sciences, 1979